Welcome to the Webinar with Dr Ken Gillman – Mastering the Classics: Unlocking the Potential of MAOIs and TCAs in Modern Psychiatry.
This webinar will take place on June 13th 2023, at 7 PM. The Webinar is recorded and will be available for on-demand viewing.
The Webinar is exclusive to Academy Members Only. [The Academy Membership gives you access to a range of online interactive courses and webinars throughout the year, with on-demand viewing available for all webinars].
If you are looking to enhance your knowledge of the clinical application of MAOIs and TCAs in modern psychiatry practice, look no further than the upcoming interview event with Dr Ken Gillman, Director and Principal Researcher at PsychoTropical Research. Dr Sanil Rege will be interviewing Dr Gillman, providing attendees with invaluable insights into using these essential treatment options in managing Major Depressive Disorder.
The event will be recorded and available for on-demand viewing for members.
While newer antidepressant medications may have gained popularity over the years, TCAs and MAOIs remain vital to psychiatric care. Attendees will benefit from a comprehensive overview of the subject, including identifying patients suitable for TCAs, how MAOIs work compared to other medications, and absolute and relative contraindications for their use.
Other key areas to be explored include when to initiate TCA and MAOI treatment, effective management of side effects, and augmentation options for patients taking MAOIs.
Don’t miss out on this unique opportunity to learn from one of the leading experts in the field of psychiatric medicine. Register now to secure your place at this must-attend event.
By attending this interview event with Dr Ken Gillman and Dr Sanil Rege, participants will:
- Develop an understanding of the clinical application of MAOIs and TCAs in modern psychiatry practice
- Identify patients who are good candidates for TCAs and gain insights into when to introduce these medications
- Compare the mechanism of action of MAOIs to SSRI, SNRI and TCAs
- Gain knowledge of the different types of MAOIs and when to use them in the management of depression
- Recognise absolute and relative contraindications for the use of MAOIs and TCAs
- Learn effective strategies for initiating treatment with MAOIs and managing their side effects
- Understand the augmentation options available for patients taking MAOIs
Speaker profile – Dr Ken Gillman
Dr Ken Gillman is a world-renowned researcher and authority in the field of psychiatry, with a focus on serotonin toxicity, monoamine oxidase inhibitor (MAOI) antidepressant drugs, and related topics. He is currently the Principal Investigator and Director at PsychoTropical Research, where he leads a team of experts who publish papers in his areas of specialization in the peer-reviewed scientific literature.
Dr Gillman’s research contributions have earned him an impressive H-index of 29 and a cumulative total of more than 4,500 citations. He has authored approximately fifteen major single-author review papers that have been extensively cited (between 100-500 times).
As the founder and convener of the International MAOI Expert Group and the Chairman of its presiding council, Dr Gillman has played a pivotal role in advancing the understanding and clinical application of MAOIs in psychiatry. He is also an invited expert participant in the Malignant Hyperthermia Association of the US (MHAUS) expert group.
With his vast expertise and groundbreaking research contributions, Dr Gillman is highly regarded as a thought leader and innovator in the field of psychiatry. His insights and perspectives are sure to enrich any discussion and deepen our understanding of the clinical application of MAOIs and TCAs in modern psychiatry practice.
Dr Sanil Rege is a consultant psychiatrist and academic, with dual qualifications from the UK and Australia. He is a Fellow of the Royal Australian and New Zealand College of Psychiatrists and a Member of the Royal College of Psychiatrists (UK).